Authors' Reply: Could Calcineurin Inhibitor-Driven Sodium-Chloride Cotransporter Activation Explain Blunted Natriuresis with Sodium-Glucose Cotransporter 2 Inhibition in Kidney Transplant Recipients?

Article B Peer reviewed Small trial

Key takeaways

A study of GLP-1 RA use in patients with kidney disease: no difference in cardiovascular or renal outcomes. This group had-stage 3 CKD patients.

Sridhar VS · Kugathasan L · Cherney DZI · Singh SKS

Article · PubMed, the drug frontier · 2026 Aug 12
https://pubmed.ncbi.nlm.nih.gov/42584954/